These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4149759)

  • 1. Adrenergic-induced vascular adjustments--initial and escape reactions. I. Influence of beta-adrenergic blocking agents on the intestinal circulation of the rat (in vivo).
    Henrich H; Singbartl G; Biester J
    Pflugers Arch; 1974 Jan; 346(1):1-12. PubMed ID: 4149759
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
    Mouillé P; Cheymol G
    C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenergic-induced vascular adjustments--initial and escape reactions. II. Role of beta-adrenergic receptors within different sections of the isolated intestinal vascular bed.
    Singbartl G; Henrich H
    Pflugers Arch; 1974 Jan; 346(1):13-24. PubMed ID: 4149758
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inotropic effects of several adrenergic beta blockers in a dog subjected to electrosystolic cardiac impulse].
    Cheymol G; Mouillé P; Schmitt H; Laubie M
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):45-51. PubMed ID: 4148408
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR; Boyles SM
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
    Klempt HW; Bender F
    Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of Kö 1366 on the distribution of intrarenal blood flow in normal canine kidneys.
    Nakamura M; Nose Y; Tomoike H; Shirai T; Kuroiwa A
    Arzneimittelforschung; 1974 Sep; 24(9):1325-8. PubMed ID: 4154766
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of beta-adrenergic blocking agents on peripheral vascular resistance.
    Rascher W; Mann JF; Schömig A; Dietz R; Lüth JB
    Klin Wochenschr; 1978; 56 Suppl 1():87-90. PubMed ID: 32434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism underlying the enchanced noradrenaline-overflow from the rabbit heart induced by the beta-adrenolytic drugs bupranolol and pindolol.
    Wagner J; Reinhardt D; Schümann HJ
    Res Exp Med (Berl); 1973 Jun; 160(4):261-8. PubMed ID: 4147104
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of newly synthesized beta-adrenergic blockers, OPC 1085 and SQ 11725, with pindolol and propranolol in the blood-perfused canine SA node and papillary muscle preparations.
    Hashimoto K; Kimura T; Yabuuchi Y
    Jpn J Pharmacol; 1976 Aug; 26(4):504-6. PubMed ID: 12390
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
    Salimi M
    Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of renin inhibition by beta adrenergic blocking agents. Effects of dl-, d-, l-propranolol and pindolol on renin release.
    Saruta T; Eguchi T; Nakamura R; Misumi J; Kondo K; Oka M
    Jpn Heart J; 1980 Jan; 21(1):103-9. PubMed ID: 6102616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
    McCaffrey PM; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
    Clark BJ; Saameli K; Troxler F
    Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental research on the action of beta-adrenergic receptor blocking agents].
    Valora N; Fidanza A; Floridi S
    Arch Fisiol; 1969 Dec; 67(3):251-72. PubMed ID: 4394262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.